2022 annual financial data
BridgeBio Pharma 2022 Net margin
BridgeBio Pharma 2022 net margin with verified reported values.
Direct answer
Net margin was -619.7%.
Operating income was -512,202,000 USD and net income was -481,183,000 USD.
Operating cash flow was -419,494,000 USD.
Get free BridgeBio Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 77,648,000 USD
- Operating income
- -512,202,000 USD
- Net income
- -481,183,000 USD
- Operating cash flow
- -419,494,000 USD